GSE108142
Epigenetic drugs selectively target a population of AML cells which are positive for CD123 cell surface markers and are chemoresistant I
Global gene expression profiling was performed on OCI-AML2 leukemia cell line, R3 and R50 drug resistant cell lines. Overall design: mRNA profiles of OCI-AML2 cells and Ara-C resistant cell lines 3R and 50R